Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.30 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18878638 | 0.90 | SIGMAR1 (0.40) | SIGMAR1LTA4HALDH1A1L3MBTL1OPRD1 | |
| SCHEMBL18878613 | 0.86 | ALDH1A1 (0.39) | LTA4HALDH1A1HTTL3MBTL1OPRD1 | |
| SCHEMBL18878751 | 0.80 | OPRD1 (0.39) | SIGMAR1LTA4HALDH1A1HTTL3MBTL1 | |
| SCHEMBL18875411 | 0.74 | OPRD1 (0.43) | SIGMAR1LTA4HALDH1A1L3MBTL1OPRD1 | |
| SCHEMBL2185063 | 0.74 | L3MBTL1 (0.50) | ALDH1A1L3MBTL1POLB | |
| SCHEMBL2185067 | 0.74 | L3MBTL1 (0.50) | ALDH1A1L3MBTL1POLB | |
| SCHEMBL18878632 | 0.73 | LTA4H (0.39) | SIGMAR1LTA4HALDH1A1L3MBTL1OPRD1 | |
| SCHEMBL14864228 | 0.71 | ALDH1A1 (0.44) | ALDH1A1HTTL3MBTL1OPRD1POLB | |
| SCHEMBL14864229 | 0.71 | ALDH1A1 (0.44) | ALDH1A1HTTL3MBTL1OPRD1POLB | |
| SCHEMBL9246161 | 0.71 | LTA4H (0.38) | LTA4HALDH1A1HTTL3MBTL1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170146549-A1 | ISOBARIC MASS LABELS | ELECTROPHORETICS LIMITED (GB) | 2017-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170146549-A1 | ISOBARIC MASS LABELS | SRMS, PTMS, QPCTL | SIGMAR1 2900/4885LTA4H 1125/4885ALDH1A1 725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.